Amaryllis Gil MD has Hematology/oncology as her primary medical specialty. Their primary office is: 177 E Brush Hill Rd in Elmhurst, Illinois.
They're a part of the: Edward Health Ventures medical group which has around 519 members. You can call their office at 331-221-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Loyola University Of Chicago, Stritch School Of Medicine and graduated in 1994 (around 30 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Amaryllis Gil MD
Edward Health Ventures
177 E Brush Hill Rd
Elmhurst, Illinois 60126
331-221-5900
Phone: 331-221-5900
Enter a starting address:
Additional Medical Specialties Include:
HOSPICE/PALLIATIVE CARE, INTERNAL MEDICINE
Medical School: Loyola University Of Chicago, Stritch School Of Medicine
Graduation Year: 1994
The Primary Medical Specialty for Amaryllis Gil MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 1254301435
NPI #: 1235116591
NPI Created On: 12/28/2005
NPI Last Updated Listed as: 09/18/2013
Primary Taxonomy Code: 207RH0003X
License Number:
36104085
Listed Gender: Female
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English, Hindi, Spanish.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835887101
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Kadcyla
Open Associated Drug #1: 50242-087-01
Drug or Biological: Biological
Product Category #2: BioOncology
Name Of Drug #2:: Phesgo
Associated Drug #2: 50242-245-01
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835887103
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Kadcyla
Open Associated Drug #1: 50242-087-01
Drug or Biological: Biological
Product Category #2: BioOncology
Name Of Drug #2:: TECENTRIQ
Associated Drug #2: 50242-917-01
Drug or Biological #3:: Biological
Product Category #3: BioOncology
Name of Drug: Phesgo
Name Of Drug #3: 50242-245-01
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835887105
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Kadcyla
Open Associated Drug #1: 50242-087-01
Drug or Biological: Biological
Product Category #2: BioOncology
Name Of Drug #2:: TECENTRIQ
Associated Drug #2: 50242-917-01
Drug or Biological #3:: Biological
Product Category #3: BioOncology
Name of Drug: Phesgo
Name Of Drug #3: 50242-245-01
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Ownership Interest: Yes
Third party is a Charity:: No
Record ID:: 835887107
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: BioOncology
Name of Drug #1: Kadcyla
Open Associated Drug #1: 50242-087-01
Drug or Biological: Biological
Product Category #2: BioOncology
Name Of Drug #2:: TECENTRIQ
Associated Drug #2: 50242-917-01
Drug or Biological #3:: Biological
Product Category #3: BioOncology
Name of Drug: Phesgo
Name Of Drug #3: 50242-245-01
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 835339537
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: SICKLE CELL DISEASE
Name of Drug #1: OXBRYTA
Open Associated Drug #1: 72786-101-01
Payments Total: $12
Number of Payments:: 1
Form of Payment: In-kind items and services
Context of payment:: ;G2783731;EPRINTS;10770919
Record ID:: 845873353
Being Disputed:: No
Product Related: Yes
Payments Total: $24
Number of Payments:: 1
Form of Payment: In-kind items and services
Record ID:: 851043573
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: Xermelo
Open Associated Drug #1: 70183-125-85
177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures
177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures
177 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures
200 Berteau Ave
Elmhurst, IL
University Of Chicago
200 Berteau Ave
Elmhurst, IL
University Of Chicago
155 E Brush Hill Rd
Elmhurst, IL
Edward Health Ventures
1200 S York St
Elmhurst Il 60126-5632
Edward Health Ventures
Family Practice
120 Spalding Dr
Naperville Il 60540-6599
Edward Health Ventures
Diagnostic Radiology
801 S Washington St
Naperville Il 60540-7430
Edward Health Ventures
Diagnostic Radiology
303 W Lake St
Addison Il 60101-2565
Edward Health Ventures
Nurse Practitioner
6701 Us Hwy 34
Oswego Il 60543-9129
Edward Health Ventures
Nurse Practitioner
2007 95th St
Naperville Il 60564-7802
Edward Health Ventures
Family Practice
View all 519 members of Edward Health Ventures medical group